NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis.
Authors | |
Keywords | |
Abstract | Environmental nutrient levels impact cancer cell metabolism, resulting in context-dependent gene essentiality. Here, using loss-of-function screening based on RNA interference, we show that environmental oxygen levels are a major driver of differential essentiality between in vitro model systems and in vivo tumours. Above the 3-8% oxygen concentration typical of most tissues, we find that cancer cells depend on high levels of the iron-sulfur cluster biosynthetic enzyme NFS1. Mammary or subcutaneous tumours grow despite suppression of NFS1, whereas metastatic or primary lung tumours do not. Consistent with a role in surviving the high oxygen environment of incipient lung tumours, NFS1 lies in a region of genomic amplification present in lung adenocarcinoma and is most highly expressed in well-differentiated adenocarcinomas. NFS1 activity is particularly important for maintaining the iron-sulfur co-factors present in multiple cell-essential proteins upon exposure to oxygen compared to other forms of oxidative damage. Furthermore, insufficient iron-sulfur cluster maintenance robustly activates the iron-starvation response and, in combination with inhibition of glutathione biosynthesis, triggers ferroptosis, a non-apoptotic form of cell death. Suppression of NFS1 cooperates with inhibition of cysteine transport to trigger ferroptosis in vitro and slow tumour growth. Therefore, lung adenocarcinomas select for expression of a pathway that confers resistance to high oxygen tension and protects cells from undergoing ferroptosis in response to oxidative damage. |
Year of Publication | 2017
|
Journal | Nature
|
Volume | 551
|
Issue | 7682
|
Pages | 639-643
|
Date Published | 2017 11 30
|
ISSN | 1476-4687
|
DOI | 10.1038/nature24637
|
PubMed ID | 29168506
|
PubMed Central ID | PMC5808442
|
Links | |
Grant list | CA168940 / NH / NIH HHS / United States
R01 CA103866 / CA / NCI NIH HHS / United States
S10 OD010584-01 / NH / NIH HHS / United States
K22 CA193660 / CA / NCI NIH HHS / United States
P30 CA016087 / CA / NCI NIH HHS / United States
K99 CA168940 / CA / NCI NIH HHS / United States
S10 OD016304 / OD / NIH HHS / United States
T32 GM115313 / GM / NIGMS NIH HHS / United States
T32 GM007308 / GM / NIGMS NIH HHS / United States
S10 OD018338 / OD / NIH HHS / United States
R37 AI047389 / AI / NIAID NIH HHS / United States
S10 OD010584 / OD / NIH HHS / United States
R01 CA129105 / CA / NCI NIH HHS / United States
R00 CA168940 / CA / NCI NIH HHS / United States
T32 AI007389 / AI / NIAID NIH HHS / United States
|